Skip to main content

Table 3 Relationship between log Triglycerides and Fetal ultrasound markers

From: Maternal cardiometabolic markers are associated with fetal growth: a secondary exploratory analysis of the LIMIT randomised trial

Ultrasound Measure

Unadjusted Estimate (95% CI)

Unadjusted p value

Adjusted Estimate (95% CI)

Adjusted p value

EFW

26.96 (−19.21, 73.13)

0.252

28.14 (−18.38, 74.67)

0.236

SSFM

0.02 (− 0.21, 0.25)

0.870

0.06 (− 0.18, 0.29)

0.633

AFM

0.02 (− 0.23, 0.27)

0.899

0.01 (− 0.24, 0.26)

0.940

MTFM

− 0.01 (− 0.32, 0.31)

0.964

− 0.00 (− 0.32, 0.32)

> 0.99

MTLM

0.08 (− 0.19, 0.34)

0.567

0.04 (− 0.23, 0.31)

0.779

AC

0.27 (− 0.07, 0.62)

0.121

0.25 (− 0.10, 0.60)

0.154

BPD

0.03 (−0.06, 0.11)

0.540

0.04 (−0.04, 0.13)

0.334

HC

−0.01 (− 0.29, 0.27)

0.946

0.03 (− 0.26, 0.32)

0.851

FL

−0.01 (− 0.07, 0.06)

0.842

0.00 (− 0.06, 0.07)

0.908

EFW z score

0.23 (0.04, 0.42)

0.020

0.20 (0.01, 0.39)

0.041

AC z score

0.30 (0.09, 0.50)

0.004

0.25 (0.05, 0.46)

0.016

BPD z score

0.25 (− 0.06, 0.55)

0.113

0.29 (− 0.02, 0.59)

0.067

HC z score

0.03 (−0.18, 0.23)

0.808

0.03 (−0.18, 0.24)

0.796

FL z score

0.05 (− 0.15, 0.26)

0.612

0.07 (− 0.14, 0.28)

0.499

  1. Results are expressed as the expected difference (ratio) and 95% confidence intervals
  2. Adjusted analyses including BMI category (< 30 vs ≥30), study centre, parity (0 vs ≥1), age at consent, smoking status and SEIFA IRSD quintile